Optogenetic cell control in experimental models of neurological disorders

Behavioural Brain Research

Volumn 255, Issue , 2013, Pages 35-43

  Tønnesen, Jan ^a,b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b University of Bordeaux   (France)

Author keywords

Animal model; Epilepsy; Neurological disorder; Optogenetic; Parkinson's disease; Retinal degeneration

Indexed keywords

LEVODOPA;

BLINDNESS; CELL TYPE; DOPAMINERGIC NERVE CELL; EPILEPSY; EXCITABILITY; GLIA CELL; HUMAN; NERVE CELL NETWORK; NEUROLOGIC DISEASE; NONHUMAN; OPTOGENETICS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RETINA CELL; RETINITIS PIGMENTOSA; REVIEW; SIGNAL TRANSDUCTION;

ANIMAL MODEL; EPILEPSY; NEUROLOGICAL DISORDER; OPTOGENETIC; PARKINSON'S DISEASE; RETINAL DEGENERATION;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; NERVOUS SYSTEM DISEASES; NEURONS; OPTOGENETICS;

EID: 84884980024     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.07.007     Document Type: Review

References (66)

1. Anderson W.S., Lenz F.A. Surgery insight: deep brain stimulation for movement disorders. Nature Clinical Practice Neurology 2006, 2:310-320.
2. Boyden E.S., Zhang F., Bamberg E., Nagel G., Deisseroth K. Millisecond-timescale, genetically targeted optical control of neural activity. Nature Neuroscience 2005, 8:1263-1268.
3. Nagel G., Ollig D., Fuhrmann M., Kateriya S., Musti A.M., Bamberg E., et al. Channelrhodopsin-1: a light-gated proton channel in green algae. Science 2002, 296:2395-2398.
4. Zhang F., Wang L.P., Brauner M., Liewald J.F., Kay K., Watzke N., et al. Multimodal fast optical interrogation of neural circuitry. Nature 2007, 446:633-639.
5. Gradinaru V., Thompson K.R., Deisseroth K. eNpHR: a Natronomonas halorhodopsin enhanced for optogenetic applications. Brain Cell Biology 2008, 36:129-139.
6. Prigge M., Schneider F., Tsunoda S.P., Shilyansky C., Wietek J., Deisseroth K., et al. Color-tuned channelrhodopsins for multiwavelength optogenetics. Journal of Biological Chemistry 2012, 287:31804-31812.
7. Petreanu L., Huber D., Sobczyk A., Svoboda K. Channelrhodopsin-2-assisted circuit mapping of long-range callosal projections. Nature Neuroscience 2007, 10:663-668.
8. Aravanis A.M., Wang L.P., Zhang F., Meltzer L.A., Mogri M.Z., Schneider M.B., et al. An optical neural interface: in vivo control of rodent motor cortex with integrated fiberoptic and optogenetic technology. Journal of Neural Engineering 2007, 4:S143-S156.
9. Bevilacqua F., Piguet D., Marquet P., Gross J.D., Tromberg B.J., Depeursinge C. In vivo local determination of tissue optical properties: applications to human brain. Applied Optics 1999, 38:4939-4950.
10. Kramer R.H., Fortin D.L., Trauner D. New photochemical tools for controlling neuronal activity. Current Opinion in Neurobiology 2009, 19:544-552.
11. Fehrentz T., Schonberger M., Trauner D. Optochemical genetics. Angewandte Chemie International Edition in English 2011, 50:12156-12182.
12. Looger L.L., Griesbeck O. Genetically encoded neural activity indicators. Current Opinion in Neurobiology 2012, 22:18-23.
13. Lin S.C., Deisseroth K., Henderson J.M. Optogenetics: background and concepts for neurosurgery. Neurosurgery 2011, 69:1-3.
14. White E. Molecular neurosurgery: vectors and vector delivery strategies. British Journal of Neurosurgery 2012, 26:798-808.
15. Tønnesen J., Parish C.L., Sorensen A.T., Andersson A., Lundberg C., Deisseroth K., et al. Functional integration of grafted neural stem cell-derived dopaminergic neurons monitored by optogenetics in an in vitro Parkinson model. PLoS ONE 2011, 6:e17560.
16. Obeso J.A., Marin C., Rodriguez-Oroz C., Blesa J., Benitez-Temino B., Mena-Segovia J., et al. The basal ganglia in Parkinson's disease: current concepts and unexplained observations. Annals of Neurology 2008, 64(Suppl. 2):S30-S46.
17. Jankovic J. Parkinson's disease: clinical features and diagnosis. Journal of Neurology, Neurosurgery & Psychiatry 2008, 79:368-376.
18. Onn S.P., Berger T.W., Grace A.A. Identification and characterization of striatal cell subtypes using in vivo intracellular recording and dye-labeling in rats: III. Morphological correlates and compartmental localization. Synapse 1994, 16:231-254.
19. Waszczak B.L., Martin L.P., Greif G.J., Freedman J.E. Expression of a dopamine D2 receptor-activated K+ channel on identified striatopallidal and striatonigral neurons. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:11440-11444.
20. Bolam J.P., Hanley J.J., Booth P.A., Bevan M.D. Synaptic organisation of the basal ganglia. Journal of Anatomy 2000, 196(Pt 4):527-542.
21. Ahlskog J.E., Muenter M.D. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Movement Disorders 2001, 16:448-458.
22. De Gaspari D., Siri C., Landi A., Cilia R., Bonetti A., Natuzzi F., et al. Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus. Journal of Neurology, Neurosurgery & Psychiatry 2006, 77:450-453.
23. Gradinaru V., Mogri M., Thompson K.R., Henderson J.M., Deisseroth K. Optical deconstruction of parkinsonian neural circuitry. Science 2009, 324:354-359.
24. Mendez J.S., Finn B.W. Use of 6-hydroxydopamine to create lesions in catecholamine neurons in rats. Journal of Neurosurgery 1975, 42:166-173.
25. Kravitz A.V., Freeze B.S., Parker P.R., Kay K., Thwin M.T., Deisseroth K., et al. Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature 2010, 466:622-626.
26. Miguelez C., Morin S., Martinez A., Goillandeau M., Bezard E., Bioulac B., et al. Altered pallido-pallidal synaptic transmission leads to aberrant firing of globus pallidus neurons in a rat model of Parkinson's disease. Journal of Physiology 2012, 590:5861-5875.
27. Bass C.E., Grinevich V.P., Vance Z.B., Sullivan R.P., Bonin K.D., Budygin E.A. Optogenetic control of striatal dopamine release in rats. Journal of Neurochemistry 2010, 114:1344-1352.
28. McCormick D.A., Contreras D. On the cellular and network bases of epileptic seizures. Annual Review of Physiology 2001, 63:815-846.
29. McNamara J.O. Emerging insights into the genesis of epilepsy. Nature 1999, 399:A15-A22.
30. Bertram E.H. Temporal lobe epilepsy: where do the seizures really begin?. Epilepsy & Behavior 2009, 14(Suppl. 1):32-37.
31. Wiebe S., Blume W.T., Girvin J.P., Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. The New England Journal of Medicine 2001, 345:311-318.
32. Blumer D., Wakhlu S., Davies K., Hermann B. Psychiatric outcome of temporal lobectomy for epilepsy: incidence and treatment of psychiatric complications. Epilepsia 1998, 39:478-486.
33. Miatton M., Van Roost D., Thiery E., Carrette E., Van Dycke A., Vonck K., et al. The cognitive effects of amygdalohippocampal deep brain stimulation in patients with temporal lobe epilepsy. Epilepsy & Behavior 2011, 22:759-764.
34. Tønnesen J., Sorensen A.T., Deisseroth K., Lundberg C., Kokaia M. Optogenetic control of epileptiform activity. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:12162-12167.
35. Wykes R.C., Heeroma J.H., Mantoan L., Zheng K., MacDonald D.C., Deisseroth K., et al. Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy. Science Translational Medicine 2012, 4:161ra52.
36. Krook-Magnuson E., Armstrong C., Oijala M., Soltesz I. On-demand optogenetic control of spontaneous seizures in temporal lobe epilepsy. Nature Communications 2013, 4:1376.
37. Paz J.T., Davidson T.J., Frechette E.S., Delord B., Parada I., Peng K., et al. Closed-loop optogenetic control of thalamus as a tool for interrupting seizures after cortical injury. Nature Neuroscience 2013, 16:64-70.
38. Sukhotinsky I., Chan A.M., Ahmed O.J., Rao V.R., Gradinaru V., Ramakrishnan C., et al. Optogenetic delay of status epilepticus onset in an in vivo rodent epilepsy model. PLoS ONE 2013, 8:e62013.
39. Paz J.T., Bryant A.S., Peng K., Fenno L., Yizhar O., Frankel W.N., et al. A new mode of corticothalamic transmission revealed in the Gria4(-/-) model of absence epilepsy. Nature Neuroscience 2011, 14:1167-1173.
40. Olsen R.W., Tobin A.J. Molecular biology of GABAA receptors. FASEB Journal 1990, 4:1469-1480.
41. Raimondo J.V., Kay L., Ellender T.J., Akerman C.J. Optogenetic silencing strategies differ in their effects on inhibitory synaptic transmission. Nature Neuroscience 2012, 15:1102-1104.
42. Chow B.Y., Han X., Dobry A.S., Qian X., Chuong A.S., Li M., et al. High-performance genetically targetable optical neural silencing by light-driven proton pumps. Nature 2010, 463:98-102.
43. Hartong D.T., Berson E.L., Dryja T.P. Retinitis pigmentosa. Lancet 2006, 368:1795-1809.
44. Jager R.D., Mieler W.F., Miller J.W. Age-related macular degeneration. The New England Journal of Medicine 2008, 358:2606-2617.
45. Werblin F.S. The retinal hypercircuit: a repeating synaptic interactive motif underlying visual function. Journal of Physiology 2011, 589:3691-3702.
46. Pitkow X., Meister M. Decorrelation and efficient coding by retinal ganglion cells. Nature Neuroscience 2012, 15:628-635.
47. Milam A.H., Li Z.Y., Fariss R.N. Histopathology of the human retina in retinitis pigmentosa. Progress in Retinal and Eye Research 1998, 17:175-205.
48. Chader G.J., Weiland J., Humayun M.S. Artificial vision: needs, functioning, and testing of a retinal electronic prosthesis. Progress in Brain Research 2009, 175:317-332.
49. Winter J.O., Cogan S.F., Rizzo J.F. Retinal prostheses: current challenges and future outlook. Journal of Biomaterials Science, Polymer Edition 2007, 18:1031-1055.
50. Bi A., Cui J., Ma Y.P., Olshevskaya E., Pu M., Dizhoor A.M., et al. Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration. Neuron 2006, 50:23-33.
51. Lagali P.S., Balya D., Awatramani G.B., Munch T.A., Kim D.S., Busskamp V., et al. Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration. Nature Neuroscience 2008, 11:667-675.
52. Doroudchi M.M., Greenberg K.P., Liu J., Silka K.A., Boyden E.S., Lockridge J.A., et al. Virally delivered channelrhodopsin-2 safely and effectively restores visual function in multiple mouse models of blindness. Molecular Therapy 2011, 19:1220-1229.
53. Zhang Y., Ivanova E., Bi A., Pan Z.H. Ectopic expression of multiple microbial rhodopsins restores ON and OFF light responses in retinas with photoreceptor degeneration. Journal of Neuroscience 2009, 29:9186-9196.
54. Greenberg K.P., Pham A., Werblin F.S. Differential targeting of optical neuromodulators to ganglion cell soma and dendrites allows dynamic control of center-surround antagonism. Neuron 2011, 69:713-720.
55. Busskamp V., Duebel J., Balya D., Fradot M., Viney T.J., Siegert S., et al. Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa. Science 2010, 329:413-417.
56. Tomita H., Sugano E., Fukazawa Y., Isago H., Sugiyama Y., Hiroi T., et al. Visual properties of transgenic rats harboring the channelrhodopsin-2 gene regulated by the thy-1.2 promoter. PLoS ONE 2009, 4:e7679.
57. Tomita H., Sugano E., Isago H., Hiroi T., Wang Z., Ohta E., et al. Channelrhodopsin-2 gene transduced into retinal ganglion cells restores functional vision in genetically blind rats. Experimental Eye Research 2010, 90:429-436.
58. Thyagarajan S., van Wyk M., Lehmann K., Lowel S., Feng G., Wassle H. Visual function in mice with photoreceptor degeneration and transgenic expression of channelrhodopsin 2 in ganglion cells. Journal of Neuroscience 2010, 30:8745-8758.
59. Busskamp V., Picaud S., Sahel J.A., Roska B. Optogenetic therapy for retinitis pigmentosa. Gene Therapy 2012, 19:169-175.
60. Nirenberg S., Pandarinath C. Retinal prosthetic strategy with the capacity to restore normal vision. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:15012-15017.
61. Uhlhaas P.J., Singer W. Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology. Neuron 2006, 52:155-168.
62. Nowak V.A., Pereira E.A., Green A.L., Aziz T.Z. Optogenetics - shining light on neurosurgical conditions. British Journal of Neurosurgery 2010, 24:618-624.
63. Han X., Qian X., Bernstein J.G., Zhou H.H., Franzesi G.T., Stern P., et al. Millisecond-timescale optical control of neural dynamics in the nonhuman primate brain. Neuron 2009, 62:191-198.
64. Diester I., Kaufman M.T., Mogri M., Pashaie R., Goo W., Yizhar O., et al. An optogenetic toolbox designed for primates. Nature Neuroscience 2011, 14:387-397.
65. Jazayeri M., Lindbloom-Brown Z., Horwitz G.D. Saccadic eye movements evoked by optogenetic activation of primate V1. Nature Neuroscience 2012, 15:1368-1370.
66. Gerits A., Farivar R., Rosen B.R., Wald L.L., Boyden E.S., Vanduffel W. Optogenetically induced behavioral and functional network changes in primates. Current Biology 2012, 22:1722-1726.